Cocaine is the second most commonly used illicit substance in Australia, after marijuana.
Articles on Dopamine
Displaying 61 - 76 of 76 articles
High fructose corn syrup in food and drinks has long been linked to rising rates of child and teen obesity. New evidence suggests it increases the risks of opioid addiction and overdose too.
Drug addiction isn’t about bad habits, fear of withdrawal or a selfish search for pleasure. It’s about the brain.
Why we love our phones so much might be related to our basic yearnings as human beings, explains a scholar, who is also a pastor.
Research has yielded new insights into Parkinson’s disease, and treatments are expanding. But a shortage of doctors trained in the disease leaves a gap in care.
2017 marks the 200th anniversary since the 1817 publication of Dr James Parkinson’s seminal work on what he called the “Shaking Palsy”.
The festive season is an intense time of year. Neuroscience can shed some light on what it does to our brains.
Are you impulsive and easily bored? You may be a thrill seeker.
Smoking causes 96,000 premature deaths a year in the UK. The fact that it protects against Parkinson’s disease is not a reason to take up the habit.
Scientists have found that there are many physical and mental benefits to volunteering.
College students who take stimulants such as Adderall to get an academic edge might be setting themselves up unknowingly to a vicious cycle of substance abuse and addiction.
Dopamine: a powerful substance that is much more than just a pleasure chemical.
Children’s insatiable curiosity and search for new knowledge is getting lost somewhere along the way. We’ve mislaid the art of the question.
Are you a “carb craver” or “chocaholic”? We often use language associated with addiction to describe our relationships with food. But is it really possible to be addicted to certain types of food?
There may be a chemical secret to getting kids interested in learning – and it’s one that’s created and produced by our own bodies rather than in a lab.
The landscape of pharmaceutical development for mental disorders has changed over recent years, with pharma companies abandoning traditional neuroscience drug discovery programs and turning instead to…
Top contributors
-
Clinical Psychologist, Lecturer and Research Supervisor, Graduate School of Health, University of Technology Sydney
-
Senior Lecturer in Neurosciences and Neurorehabilitation, Course Leader in the College of Health and Life Sciences, London South Bank University
-
Assistant Professor of Psychology, Concordia University
-
Professor of Neuroscience, University of Florida
-
Professor of Clinical Neuropsychology, University of Cambridge
-
Associate Professor of Health and Wellness Studies, Binghamton University, State University of New York
-
Senior Lecturer (Adjunct), Nutritional neuroscientist, Adelaide University
-
Postdoctoral Research Associate, Cognitive Neuroscience, University of Cambridge
-
Associate Professor in Education & Technology, University of KwaZulu-Natal
-
Professor of Neurology, Norman Fixel Institute, University of Florida
-
Lead, Cognition and Consciousness Imaging Group, Division of Anaesthesia, University of Cambridge
-
Lecturer in Psychology and Neuroscience, University of St Andrews
-
Contract Lecturer in Digital Media, Toronto Metropolitan University
-
PhD Candidate Nutrition and Dietetics, University of Newcastle
-
Postdoctoral Researcher in Neuroscience, University of Sussex